Utah has reported 27 cases so far; Arizona has 42 confirmed cases, including 1 child who has been hospitalized.
HealthDay News — Psilocybin-assisted therapy (PAT) shows long-term safety and efficacy for treating symptoms of major depressive disorder (MDD), according to a study published in the Journal of ...
Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.
HealthDay News — During August 2021 to August 2023, only 36.4% of US adults had no cardiovascular disease (CVD) risk factors, according to a September data brief published by the National Center for ...
HealthDay News — The US Food and Drug Administration (FDA) has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ...
Researchers explored the impact of polypharmacy on long-term treatment response among patients with early rheumatoid arthritis.
North Carolina and Idaho are cutting their Medicaid programs to bridge budget gaps, raising fears that providers will stop taking patients.
Psychosocial symptoms improved with encounters with a behavioral health clinician and psychotropic prescription.
Maxillary sinusitis is characterized by facial pain and pressure in the cheek area that worsens with bending over or lying ...
Helen Tager-Flusberg, director of the Center for Autism Research Excellence at Boston University, called Trump’s comments dangerous. Fevers can harm the mother and the developing fetus, she said, ...
Vaccination against measles, mumps, rubella, and varicella is typically administered in 2 doses: the first between 12 to 15 months and the second at 4 to 6 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results